Improving Hepatitis B and C Care Cascades; Focus on Increased Testing and Diagnosis (CDC-RFA-PS17-1702)

Period Length: 4 years

This program will increase the number of persons living with hepatitis B and hepatitis C infection that are tested for these infections, made aware of their infection, and linked to recommended care and treatment services.

CDC has awarded funding to 46 U.S. states, three cities, and the District of Columbia:

  • Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Indiana, Iowa, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, New Hampshire, New Jersey, New Mexico, Nevada, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming
  • Chicago, New York City, Philadelphia
  • Washington, DC


Funding for the four-year project period is expected to be approximately $5.7M each year.

For existing/current 1702 awardees, applications under a supplement, CDC-RFA-PS17-17020301SUPP19, can now be accepted through grants.govexternal icon

Info Brief